News Focus
News Focus
icon url

DJPele

11/18/22 6:08 PM

#535272 RE: Grip it and Sip It #535271

If Twitter, a social media company, is worth $44B, then NWBO is worth more than that.
icon url

Hopeforthefuture3

11/18/22 6:54 PM

#535288 RE: Grip it and Sip It #535271

Grip it 10 to $12 a share for me would be a dream come true. Anything more imo is welcomed but difficult to come by - at least in the near term imo
icon url

DavidW2

11/18/22 6:56 PM

#535289 RE: Grip it and Sip It #535271

I believe Soj's $12 target eventually will meet. It will get there in year 2023....
icon url

Extremist223

11/18/22 7:25 PM

#535301 RE: Grip it and Sip It #535271

If you compare NWBO to Kite and Juno you will see that $10-12/share is way too low.

They were CAR-T therapies (living cells like DCVAX) however there are major differences that make NWBO worth way more.

For example, those CAR-T therapies were generating single antigen T-cells instead of the full personalized repertoire.

2nd example, our phase 3 data set opens the door to a biomarker approval for MGMT methylated patients irrespective of tumor location. That market is way larger than attacking cd19 on acute lymphoblastic leukemia.

$40 is not impossible and that doesn't include any exuberance in trading and spikes that are seen in markets.

We need to get biotech sector moving, I've researched enough. Dendritic cell replacement is a staple that should've been offered years ago.

The entire market is pretty pathetic that's what makes the possibility for NWBO even stronger.. Everyone knows the whole market is trash right now.

Look and see for yourself...



A fake ass market is exactly how one can be a market maker and take both sides of every ticker, at all times, and somehow not go bankrupt. They sold you turds everywhere you look. Share prices bleed forever and then rise super quick and then they bleed again forever.
Bullish
Bullish
icon url

hump4

11/18/22 11:36 PM

#535381 RE: Grip it and Sip It #535271

You have no idea what you are talking about. Twitter sold for $44B. The NWBO story is phenomenal. The fact that it could address all solid tumor cancers off label could make this a $300 PPS. It could easily get wind in the sails as a meme stock. Perhaps not right away but with a UK approval around the corner this will take off as soon as they cross that first milestone.